These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
997 related articles for article (PubMed ID: 28431566)
1. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer. Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566 [TBL] [Abstract][Full Text] [Related]
2. A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio. Wei XL; Wang FH; Zhang DS; Qiu MZ; Ren C; Jin Y; Zhou YX; Wang DS; He MM; Bai L; Wang F; Luo HY; Li YH; Xu RH BMC Cancer; 2015 May; 15():350. PubMed ID: 25934640 [TBL] [Abstract][Full Text] [Related]
3. A Novel Inflammation-Based Prognostic Score, the C-Reactive Protein/Albumin Ratio Predicts the Prognosis of Patients with Operable Esophageal Squamous Cell Carcinoma. Xu XL; Yu HQ; Hu W; Song Q; Mao WM PLoS One; 2015; 10(9):e0138657. PubMed ID: 26390126 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma. Chen Z; Shao Y; Fan M; Zhuang Q; Wang K; Cao W; Xu X; He X Int J Clin Exp Pathol; 2015; 8(11):14893-900. PubMed ID: 26823819 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of the Preoperative Ratio of C-Reactive Protein to Albumin in Patients with Colorectal Cancer. Shibutani M; Maeda K; Nagahara H; Iseki Y; Ikeya T; Hirakawa K Anticancer Res; 2016 Mar; 36(3):995-1001. PubMed ID: 26976989 [TBL] [Abstract][Full Text] [Related]
6. The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Kinoshita A; Onoda H; Imai N; Iwaku A; Oishi M; Tanaka K; Fushiya N; Koike K; Nishino H; Matsushima M Ann Surg Oncol; 2015 Mar; 22(3):803-10. PubMed ID: 25190127 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer. Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825 [TBL] [Abstract][Full Text] [Related]
8. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy. Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854 [TBL] [Abstract][Full Text] [Related]
9. Significance of the Glasgow Prognostic Score as a prognostic indicator for lung cancer surgery. Kawashima M; Murakawa T; Shinozaki T; Ichinose J; Hino H; Konoeda C; Tsuchiya T; Murayama T; Nagayama K; Nitadori J; Anraku M; Nakajima J Interact Cardiovasc Thorac Surg; 2015 Nov; 21(5):637-43. PubMed ID: 26269495 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer. Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695 [TBL] [Abstract][Full Text] [Related]
11. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma. Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304 [TBL] [Abstract][Full Text] [Related]
12. The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer. Wu M; Guo J; Guo L; Zuo Q Tumour Biol; 2016 Sep; 37(9):12525-12533. PubMed ID: 27344157 [TBL] [Abstract][Full Text] [Related]
13. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients. Song A; Eo W; Lee S World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of C-reactive protein/albumin ratio in predicting overall survival of Chinese cervical cancer patients overall survival: comparison among various inflammation based factors. He X; Li JP; Liu XH; Zhang JP; Zeng QY; Chen H; Chen SL J Cancer; 2018; 9(10):1877-1884. PubMed ID: 29805715 [No Abstract] [Full Text] [Related]
15. C-Reactive Protein/Albumin Ratio Is an Independent Prognostic Predictor of Survival in Advanced Cancer Patients Receiving Palliative Care. Zhang J; Zhang C; Li Q; Zhang J; Gu X; Zhao W; Chen M; Liu M; Zhang Z; Liao X; Cheng W J Palliat Med; 2019 Dec; 22(12):1536-1545. PubMed ID: 31188054 [No Abstract] [Full Text] [Related]
16. The C-Reactive Protein/Albumin Ratio Is Useful for Predicting Short-Term Survival in Cancer and Noncancer Patients. Miyamoto T; Fujitani M; Fukuyama H; Hatanaka S; Koizumi Y; Kawabata A J Palliat Med; 2019 May; 22(5):532-537. PubMed ID: 30570426 [No Abstract] [Full Text] [Related]
17. The Ratio of C-Reactive Protein/Albumin is a Novel Inflammatory Predictor of Overall Survival in Cisplatin-Based Treated Patients with Metastatic Nasopharyngeal Carcinoma. Sun P; Chen C; Xia Y; Bi X; Liu P; Zhang F; Yang H; An X; Jiang W; Wang F Dis Markers; 2017; 2017():6570808. PubMed ID: 28676731 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma. Li YJ; Yao K; Lu MX; Zhang WB; Xiao C; Tu CQ Onco Targets Ther; 2017; 10():5255-5261. PubMed ID: 29138578 [TBL] [Abstract][Full Text] [Related]
19. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer. Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541 [TBL] [Abstract][Full Text] [Related]
20. Preoperative platelet/lymphocyte ratio is a superior prognostic factor compared to other systemic inflammatory response markers in ovarian cancer patients. Zhang WW; Liu KJ; Hu GL; Liang WJ Tumour Biol; 2015 Nov; 36(11):8831-7. PubMed ID: 26063409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]